Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Comparing XEN®-63 Gel Stent and PRESERFLO® MicroShunt [NA]

View source ↗

Summary

A clinical trial to compare the XEN-63 Gel Stent with the PRESERFLO MicroShunt for open-angle glaucoma is currently recruiting at Universitaire Ziekenhuizen KU …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PreserFlo MicroShunt
  • XEN-63 Gel Stent

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: GLAUCOMA 1, OPEN ANGLE, D (Disorder) | NA | Status: RECRUITING